Hook & thesis
Alstom ADR (ALSMY) has slid from recent 10-50 day moving averages into deeply oversold territory, yet the company's commercial momentum remains intact. The market has focused on short-term price action rather than the underlying order book: management reported record order intake in Q3 FY2025/26 and a backlog above €100 billion — a multi-year revenue visibility cushion. For an investor willing to trade around the near-term noise, ALSMY offers asymmetric upside with a defined stop-loss.
My trade thesis: buy on the current weakness for a recovery trade over the next 46-180 trading days, with a smaller tactical leg for a short-term oversold bounce. The technicals argue for a mean reversion (RSI ~23), while fundamental catalysts — large contracts in Europe and Canada and continued order momentum — underwrite medium-term revenue growth.
What the company does and why the market should care
Alstom is a global rail infrastructure and rolling stock company that designs, builds and services trains, signalling systems and turnkey rail projects. For capital allocators, two fundamental drivers matter: (1) the size and quality of the order book that converts to multi-year revenue, and (2) recurring operations & maintenance contracts that provide steady service revenue. Both drivers are visible in Alstom's recent announcements.
On 01/20/2026, management reported record Q3 order intake of €9.6 billion and a backlog of €100.3 billion, while Q3 sales were €4.8 billion, growing 2.6% reported and 5.9% on an organic basis. Those figures point to sustained demand for rolling stock and signalling solutions across Europe and abroad — the sort of structural visibility that supports a multi-quarter recovery even if near-term trading is volatile.
Recent commercial wins (why this matters)
- 04/08/2026 - New signalling contract in Europe worth €295 million (booked in Q4 FY2025/26) — continues to show strength in high-margin digital signalling.
- 03/20/2026 - Renewal of a 5-year operations & maintenance contract with Metrolinx in Toronto, valued at ~€800 million (extends service through 2031) — underlines the recurring revenue profile in North America.
- 03/10/2026 - €1.03 billion contract to supply 153 Adessia Stream trains to Comboios de Portugal and a new factory in Matosinhos — meaningful rolling stock win with local manufacturing and job creation.
Supporting numbers
Translate those commercial indicators into simple takeaways: order intake in Q3 more than doubled year-on-year to €9.6 billion; backlog reached €100.3 billion; and sales in Q3 were €4.8 billion (2.6% reported growth, 5.9% organic). That combination — rising order intake, a growing backlog and modest top-line growth — is a textbook reason to own cyclicals through the trough: orders lead revenue.
Technicals and market microstructure
Price sits around $1.91 after opening at $1.89 and intraday high of $2.00. Key technicals show meaningful short-term weakness but oversold momentum:
| Indicator | Value |
|---|---|
| SMA 10 | $2.58 |
| SMA 20 | $2.64 |
| SMA 50 | $2.93 |
| EMA 9 | $2.45 |
| RSI (momentum) | 23.3 (oversold) |
| MACD | Bearish momentum; MACD line -0.150 vs signal -0.092 |
Those moving averages are well above the current price, indicating the decline has been swift and mechanically driven. The RSI at ~23 is far into oversold territory, which historically increases the odds of a relief rally. Microstructure data shows heavy short activity recently — large short-volume days at the most recent trading session — which can both pressure price lower and create the conditions for sharp squeezes if sentiment turns.
Valuation framing
ALSMY is quoted as an ADR on the OTC market and trades at a low single-digit share price. Public market capitalization information is not the focus for this trade; instead, valuation should be framed against backlog and revenue conversion. A €100.3 billion backlog (book-to-bill well above 1 in the latest quarter) implies substantial multi-year revenue visibility compared with the market's current low-valuation pricing of the ADR. In plain terms: the market is giving a low price to a company with a global order book that supports future top-line and margin recovery.
This disconnect argues for buying the pullback as a risk-defined trade rather than attempting to benchmark a precise multiple in an OTC ADR where pricing is volatile and institutional coverage is lighter than for main exchange-listed peers.
Catalysts to drive the trade
- Q4 FY2025/26 booking conversion and order intake updates that reaffirm backlog convertibility and margin trends.
- Delivery starts or manufacturing milestones (e.g., Portugal factory build) that demonstrate progress from backlog to revenue.
- Renewals / expansion of operations & maintenance contracts (e.g., North America) that lift recurring service revenue visibility.
- Technical rebound: reduction in short-volume and an uptick in daily closes above the 10-day SMA would likely attract momentum buyers.
Trade plan (actionable)
Entry: $1.92
Target: $3.25
Stop-loss: $1.60
Position size guidance: Keep this as a smaller-sized position relative to core holdings — this is a trade that blends fundamental support with technical entry. Expect volatility and size the position so a move to stop-loss represents acceptable capital at risk.
Time horizon: Primary trade horizon is long term (180 trading days) because backlog conversion to revenue and margin improvement is expected to play out over multiple quarters. There is also merit in a short-term tactical leg: short term (10 trading days) for an RSI-driven bounce target near $2.50 if the market sees a relief rally; mid term (45 trading days) if delivery milestones or contract clarifications arrive sooner than expected.
Why those levels? Entry at $1.92 buys near current prices while leaving room for intraday noise. Stop at $1.60 limits downside to a clear technical invalidation (below recent lows and psychological round numbers). The $3.25 target is conservative versus historical moving averages and allows for a meaningful recovery toward the 20-50 day SMA band; it prices in improved sentiment and partial backlog monetization without assuming a full re-rating.
Risks and counterarguments
- Execution risk on backlog conversion - A large backlog does not automatically mean near-term revenue. Delays in projects, supply-chain bottlenecks or inflationary cost overruns could compress margins and push revenue delivery timelines out.
- Macroeconomic / funding risk - Governments and transit agencies are the primary customers; budget tightening or shifting political priorities could delay large orders and renewals.
- Sentiment & liquidity risk - ALSMY trades OTC with thinner liquidity and high short activity. That can amplify downside and make it harder to exit positions quickly at desired prices.
- Currency & regional risk - Large contracts are denominated in euros; currency swings and local content rules can affect margins and pace of deliveries in different geographies.
- Competitive / protectionism risk - Local content mandates and protectionist policies can limit access to certain markets, which would reduce addressable opportunity despite backlog size.
Counterargument: The most convincing bear case is that the market is pricing in near-term margin erosion or a slowdown in the speed at which backlog converts to revenue. If major contracts hit unexpected execution problems or margins compress more than anticipated, the ADR could trade lower for an extended period. That is a legitimate outcome, and it is why the trade includes a strict stop and modest position sizing.
Conclusion and what would change my mind
ALSMY is a buy here for an investor willing to accept OTC liquidity and higher volatility in exchange for exposure to a company with a €100bn-plus backlog and confirmed FY outlook. The entry offered by the recent weakness, combined with oversold technicals and heavy short activity, creates a favourable risk-reward for a long-term recovery trade. The trade is not without risk; failures in execution, margin pressure or worsening macro conditions could invalidate the thesis.
I would change my view and move to neutral/avoid if: a) management materially revises backlog convertibility or earnings guidance downward, b) new evidence appears of prolonged supply-chain disruption that delays deliveries beyond a year, or c) short-selling pressure continues to compound without any improvement in order conversion or margin outlook. Conversely, clear evidence of converting backlog into visible quarterly revenue growth and margin stabilization would reinforce the bullish case and warrant increasing exposure.
Key takeaways
- Alstom ADR has durable commercial momentum despite near-term price weakness — record orders and a €100.3bn backlog are the backbone of the bullish case.
- Technically oversold (RSI ~23) and showing heavy short activity, creating a setup for a relief rally and potential squeeze.
- Trade idea: buy at $1.92, stop $1.60, target $3.25. Primary horizon: long term (180 trading days) with a tactical short-term (10 trading days) opportunity for a bounce.
- Maintain disciplined position sizing and watch for execution and margin risks; adjust the view if guidance or backlog conversion weakens materially.
Trade plan recap: Entry $1.92 | Target $3.25 | Stop $1.60 | Primary horizon: long term (180 trading days). Keep position size controlled due to OTC liquidity and execution risk.